Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Xipurui Bioengineering is a biotechnology company specializing in the large-scale cultivation of Haematococcus pluvialis and the extraction of natural astaxanthin. Based in Kunming, Yunnan, the company utilizes the region's high-altitude sunlight and clean water resources to produce high-quality microalgae-derived antioxidants. Their business model integrates R&D, industrial cultivation in photobioreactors, and advanced supercritical CO2 extraction to produce astaxanthin oleoresin and powders. The company's products are primarily supplied to the global dietary supplement, functional food, and cosmetic industries. Xipurui operates under strict GMP standards and is recognized as a key high-tech enterprise in the Yunnan province microalgae sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Shippurui Bioengineering.